Stock listing

Zelira Therapeutics Ltd.

Selected listing: A2AS5H · LS · EUR · DE

Zelira Therapeutics Ltd. (Lang & Schwarz: A2AS5H), Health Technology. Latest release Aug 24, 2026: Suspension from Official Quotation - Annual Listing Fees.

A2AS5H:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A2AS5H
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Other
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Zelira Therapeutics Ltd.

Suspension from Official Quotation - Annual Listing Fees

August 23, 2026

Long Term Suspended Entities

July 10, 2026

Suspension from Quotation

March 1, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

January 28, 2026

Transformative US$33M Fundraising into Zeliras HOPE 1 SPV

January 15, 2026

All Zelira Therapeutics Ltd. news →

Research Zelira Therapeutics Ltd.

Zelira Therapeutics Ltd. company profile

View the public company page for Zelira Therapeutics Ltd. on 6ix.

Zelira Therapeutics Ltd. news

Read company news and market updates connected to Zelira Therapeutics Ltd..

Zelira Therapeutics Ltd. investor events

Find investor webinars, events, and replay context for Zelira Therapeutics Ltd..